Effects of nicotine chewing gum on UPDRS score and P300 in early-onset Parkinsonism

Hiroshima Journal of Medical Sciences

Volumn 51, Issue 1, 2002, Pages 33-39

  Mitsuoka, Takako ^a   Kaseda, Yumiko ^a   Yamashita, Hiroshi ^a   Kohriyama, Tatsuo ^a   Kawakami, Hideshi ^a   Nakamura, Shigenobu ^a   Yamamura, Yasuhiro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Early onset parkinsonism; Nicotine chewing gum; P300; UPDRS

Indexed keywords

NICOTINE GUM;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; EVOKED AUDITORY RESPONSE; EVOKED RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MALE; NEUROPROTECTION; PARKINSON DISEASE; PARKINSONISM; RATING SCALE; SCORING SYSTEM; SMOKING;

ADULT; CHEWING GUM; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PARKINSONIAN DISORDERS; REACTION TIME; SMOKING;

EID: 0036241597     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity
2. Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain. Evidence for nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems
3. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders
4. Cigarette smoking and Parkinson's disease
5. The human costs of tobacco use (1)
6. Cigarette smoking and Parkinson disease: 1. Comparison of cases with matched neighbors
7. Determinants of nicotine intake while chewing nicotine polacrilex gum
8. Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys
9. Cholinergic 'Blockade' as a model of the cognitive deficits in Alzheimer's disease
10. The short-term effect of nicotine chewing gum in patients with Parkinson's disease
11. Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study
12. Dementia: The neurochemical basis of putative transmitter orientated therapy
13. In vitro neuroprotective properties of novel cholinergic channel activator (ChCA) ABT-418
14. Nicotine may relieve symptoms of Parkinson's disease
15. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program
16. Efficacy of cigarette smoking on five cases with juvenile Parkinsonism
17. Effects of smoking in patients with early-onset Parkinson's disease
18. Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: An analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat
19. Beneficial effects of nicotine
20. Objective evaluation of fatigue by event-related potentials
21. Effects of nicotine chewing gum in patients with early-onset parkinsonism
22. Mutation in the Parkin gene cause autosomal recessive juvenile parkinsonism
23. A double blind study of 2 mg versus 4 mg nicotine-gum in an industrial setting
24. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease
25. Basic and clinical psychopharmacology of nicotine
26. Nicotinic systeme and cognitive function
27. Distribution of polonium-210 in pulmonary tissues of cigarette smokers
28. Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism
29. Parkinson's disease
30. Smoking and coronary heart disease
31. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder
32. Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
33. The role of nicotine and nicotinic mechanisms in neuropsychiatric disease
34. Neuroendocrine, physiologic and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease
35. Intravenous nicotine in Alzheimer's disease: A pilot study
36. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography
37. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's disease
38. Epibatidine: A nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: In vitro and in vivo evidence in rats
39. Gene expression of the nicotinic acetylcholine receptor alpha 4 subunit in the frontal cortex in Parkinson's disease patients
40. Two and four mg nicotine chewing gum and group counselling in smoking cessation: An open, randomized, controlled trial with a 22 month follow-up
41. Effect of nicotine chewing gum in combination with group counselling on the cessation of smoking
42. Nicotine as a therapeutic drug
43. Reductions in [3H] nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autoradiologic study
44. Presynaptic nicotinic ACh receptors
45. Early-onset parkinsonism with diurnal fluctuation-clinical and pathological studies
46. Effect of nicotine on dopamine uptake on COS cells possessing the rat dopamine transporter and in PC12
47. Nicotine rescues PC12 Cells from death induced by nerve growth factor deprivation